PubMed

Transparency in Nigeria's public pharmaceutical sector: perceptions from policy makers.

Garuba HA, Kohler JC, Huisman AM.

Global Health. 2009 Oct 29;5:14.PMID: 19874613 [PubMed]Free PMC ArticleFree textRelated citations

Tackling corruption in the pharmaceutical systems worldwide with courage and conviction.

Cohen JC, Mrazek M, Hawkins L.

Clin Pharmacol Ther. 2007 Mar;81(3):445-9. Epub 2007 Jan 24. Review.PMID: 17251983 [PubMed - indexed for MEDLINE]Related citations

Problems associated with substandard and counterfeit drugs in developing countries: a review article on global implications of counterfeit drugs in the era of antiretroviral (ARVs) drugs in a free market economy.

Nsimba SE.

East Afr J Public Health. 2008 Dec;5(3):205-10. Review.PMID: 19374325 [PubMed - indexed for MEDLINE]Related citations

Synergies between veterinarians and para-professionals in the public and private sectors: organisational and institutional relationships that facilitate the process of privatising animal health services in developing countries.

Woodford JD.

Rev Sci Tech. 2004 Apr;23(1):115-35; discussion 391-401. Review.PMID: 15200091 [PubMed - indexed for MEDLINE]Related citations

Drug supply strategies, constraints and prospects in Nigeria.

Yusuff KB, Tayo F.

Afr J Med Med Sci. 2004 Dec;33(4):389-94.PMID: 15977451 [PubMed - indexed for MEDLINE]Related citations

Improving health workforce recruitment and retention in rural and remote regions of Nigeria.

Awofeso N.

Rural Remote Health. 2010 Jan-Mar;10(1):1319. Epub 2010 Feb 4.PMID: 20136347 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

The potential of health sector non-governmental organizations: policy options.

Gilson L, Sen PD, Mohammed S, Mujinja P.

Health Policy Plan. 1994 Mar;9(1):14-24.PMID: 10133097 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Procedures and methods of benefit assessments for medicines in Germany.

Bekkering GE, Kleijnen J.

Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29.PMID: 18987905 [PubMed - indexed for MEDLINE]Related citations

National data system on near miss and maternal death: shifting from maternal risk to public health impact in Nigeria.

Oladapo OT, Adetoro OO, Fakeye O, Ekele BA, Fawole AO, Abasiattai A, Kuti O, Tukur J, Ande AB, Dada OA; Nigerian Network for Reproductive Health Research and Training (NNRHRT).

Reprod Health. 2009 Jun 9;6:8.PMID: 19508717 [PubMed]Free PMC ArticleFree textRelated citations

The World Bank and pharmaceuticals.

Falkenberg T, Tomson G.

Health Policy Plan. 2000 Mar;15(1):52-8.PMID: 10731235 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Health care for some: a Nigerian study of who gets what, where and why?

Stock R.

Int J Health Serv. 1985;15(3):469-84.PMID: 4055185 [PubMed - indexed for MEDLINE]Related citations

Pharmaceuticals--strategic considerations in health reforms in Pakistan.

Nishtar S.

J Pak Med Assoc. 2006 Dec;56(12 Suppl 4):S100-11.PMID: 17595837 [PubMed - indexed for MEDLINE]Related citations

[An analysis of the pharmaceuticals market in Vietnam]

Simonet D.

Sante. 2001 Jul-Sep;11(3):155-60. French. PMID: 11641078 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Impact of decentralization on health services in Uganda: a look at facility utilization, prescribing and availability of essential drugs.

Anokbonggo WW, Ogwal-Okeng JW, Obua C, Aupont O, Ross-Degnan D.

East Afr Med J. 2004 Feb;Suppl:S2-7.PMID: 15125109 [PubMed - indexed for MEDLINE]Related citations

A Cost-Effective Model for Increasing Access to Mental Health Care at the Primary Care Level in Nigeria.

Omigbodun OO.

J Ment Health Policy Econ. 2001 Sep 1;4(3):133-139.PMID: 11967473 [PubMed - as supplied by publisher]Related citations

[Procedures and methods of benefit assessments for medicines in Germany]

Bekkering GE, Kleijnen J.

Dtsch Med Wochenschr. 2008 Dec;133 Suppl 7:S225-46. Epub 2008 Nov 25. German. PMID: 19034813 [PubMed - indexed for MEDLINE]Related citations

Primary Care Research Team Assessment (PCRTA): development and evaluation.

Carter YH, Shaw S, Macfarlane F.

Occas Pap R Coll Gen Pract. 2002 Feb;(81):iii-vi, 1-72.PMID: 12049028 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

[Development of antituberculous drugs: current status and future prospects]

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese. PMID: 17240921 [PubMed - indexed for MEDLINE]Related citations

Medical doctors profile in Ethiopia: production, attrition and retention. In memory of 100-years Ethiopian modern medicine & the new Ethiopian millennium.

Berhan Y.

Ethiop Med J. 2008 Jan;46 Suppl 1:1-77.PMID: 18709707 [PubMed - indexed for MEDLINE]Related citations

Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug.

Mubyazi GM, Gonzalez-Block MA.

Malar J. 2005 Oct 20;4:51.PMID: 16242017 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations